BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21859801)

  • 1. Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Tandri H; Duffy ER; Winterfield JR; Mackey-Bojack S; Picken MM; Cooper LT; Wilber DJ; Marcus FI; Basso C; Thiene G; Tsatsopoulou A; Protonotarios N; Stevenson WG; McKenna WJ; Gautam S; Remick DG; Calkins H; Saffitz JE
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):743-52. PubMed ID: 21859801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
    Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
    Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Tandri H; Huang H; Halushka MK; Gautam S; Basso C; Thiene G; Tsatsopoulou A; Protonotarios N; McKenna WJ; Calkins H; Saffitz JE
    N Engl J Med; 2009 Mar; 360(11):1075-84. PubMed ID: 19279339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling.
    Li J; Swope D; Raess N; Cheng L; Muller EJ; Radice GL
    Mol Cell Biol; 2011 Mar; 31(6):1134-44. PubMed ID: 21245375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
    Kirchhof P; Fabritz L; Zwiener M; Witt H; Schäfers M; Zellerhoff S; Paul M; Athai T; Hiller KH; Baba HA; Breithardt G; Ruiz P; Wichter T; Levkau B
    Circulation; 2006 Oct; 114(17):1799-806. PubMed ID: 17030684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy.
    Li D; Liu Y; Maruyama M; Zhu W; Chen H; Zhang W; Reuter S; Lin SF; Haneline LS; Field LJ; Chen PS; Shou W
    Hum Mol Genet; 2011 Dec; 20(23):4582-96. PubMed ID: 21880664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.
    Noorman M; Hakim S; Kessler E; Groeneweg JA; Cox MG; Asimaki A; van Rijen HV; van Stuijvenberg L; Chkourko H; van der Heyden MA; Vos MA; de Jonge N; van der Smagt JJ; Dooijes D; Vink A; de Weger RA; Varro A; de Bakker JM; Saffitz JE; Hund TJ; Mohler PJ; Delmar M; Hauer RN; van Veen TA
    Heart Rhythm; 2013 Mar; 10(3):412-9. PubMed ID: 23178689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
    Garcia-Gras E; Lombardi R; Giocondo MJ; Willerson JT; Schneider MD; Khoury DS; Marian AJ
    J Clin Invest; 2006 Jul; 116(7):2012-21. PubMed ID: 16823493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of plakoglobin immunoreactivity in intercalated discs in arrhythmogenic right ventricular cardiomyopathy: protein mislocalization versus epitope masking.
    Kant S; Krusche CA; Gaertner A; Milting H; Leube RE
    Cardiovasc Res; 2016 Feb; 109(2):260-71. PubMed ID: 26676851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy.
    Vimalanathan AK; Ehler E; Gehmlich K
    Biophys Rev; 2018 Aug; 10(4):973-982. PubMed ID: 29995277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships Between Clinical Characteristics and Decreased Plakoglobin and Connexin 43 Expressions in Myocardial Biopsies From Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Yoshida T; Kawano H; Kusumoto S; Fukae S; Koga S; Ikeda S; Koide Y; Abe K; Hayashi T; Maemura K
    Int Heart J; 2015; 56(6):626-31. PubMed ID: 26549284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cardiac myocyte cohesion and gap junctions via desmosomal adhesion.
    Schinner C; Erber BM; Yeruva S; Waschke J
    Acta Physiol (Oxf); 2019 Jun; 226(2):e13242. PubMed ID: 30582290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular changes in the heart of a severe case of arrhythmogenic right ventricular cardiomyopathy caused by a desmoglein-2 null allele.
    Gehmlich K; Syrris P; Reimann M; Asimaki A; Ehler E; Evans A; Quarta G; Pantazis A; Saffitz JE; McKenna WJ
    Cardiovasc Pathol; 2012; 21(4):275-82. PubMed ID: 22036071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-Kinase Inhibition During Early Cardiac Development Causes Arrhythmogenic Right Ventricular Cardiomyopathy in Mice.
    Ellawindy A; Satoh K; Sunamura S; Kikuchi N; Suzuki K; Minami T; Ikeda S; Tanaka S; Shimizu T; Enkhjargal B; Miyata S; Taguchi Y; Handoh T; Kobayashi K; Kobayashi K; Nakayama K; Miura M; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2172-84. PubMed ID: 26315406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations.
    Gehmlich K; Syrris P; Peskett E; Evans A; Ehler E; Asimaki A; Anastasakis A; Tsatsopoulou A; Vouliotis AI; Stefanadis C; Saffitz JE; Protonotarios N; McKenna WJ
    Cardiovasc Res; 2011 Apr; 90(1):77-87. PubMed ID: 21062920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac desmosomal (dys)function and myocyte viability.
    Remme CA; Bezzina CR
    Cell Cycle; 2010 Apr; 9(7):1246-52. PubMed ID: 20305388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of cell-cell junctions in arrhythmogenic cardiomyopathy.
    Asimaki A; Saffitz JE
    Cell Commun Adhes; 2014 Feb; 21(1):13-23. PubMed ID: 24460198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy.
    Dokuparti MVN; Pamuru PR; Thakkar B; Tanjore RR; Nallari P
    J Hum Genet; 2005; 50(8):375-381. PubMed ID: 16096717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.